Skip to Content
Merck
CN
  • Evaluation of biotransformed berberine derivatives as anti inflammatory drugs: an in silico study.

Evaluation of biotransformed berberine derivatives as anti inflammatory drugs: an in silico study.

Interdisciplinary sciences, computational life sciences (2013-01-29)
Chandra D Naveen, G K Prasanth, C Sadasivan, M Haridas
ABSTRACT

The anti inflammatory potential of the human and microbial biotransformed derivatives of berberine were determined by molecular docking. It was revealed that almost all derivatives formed as a result of biotransformation showed increase in phospholipase A(2) binding affinity compared to berberine. The newly introduced -OH group/groups establish stronger hydrogen bonding interactions and more number of van der Waals contacts with the protein. As phospholipase A(2) is a target of anti inflammatory drugs, it might be concluded that certain biotransformed derivatives of berberine could be better anti inflammatory agents compared to berberine.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phospholipase A2 from honey bee venom (Apis mellifera), salt-free, lyophilized powder, 600-2400 units/mg protein
Sigma-Aldrich
Phospholipase A2 from porcine pancreas, ammonium sulfate suspension, ≥600 units/mg protein
Sigma-Aldrich
Phospholipase A2 from bovine pancreas, lyophilized powder, ≥20 units/mg protein